Detailed TOC of Global Cell and Gene Therapy Market Research Report 2026
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Market Size Growth Rate by Type: 2021 VS 2026 VS 2035
1.2.2 Rare Diseases
1.2.3 Oncology
1.2.4 Hematology
1.2.5 Cardiovascular
1.2.6 Ophthalmology
1.2.7 Neurology
1.2.8 Other Therapeutic Classes
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Market Growth by Application: 2021 VS 2026 VS 2035
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Contract Research Organizations (CROs)
1.3.5 Hospital
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Market Perspective (2021-2035)
2.2 Cell and Gene Therapy Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Market Size by Region: 2021 VS 2026 VS 2035
2.2.2 Cell and Gene Therapy Historic Market Size by Region (2021-2026)
2.2.3 Cell and Gene Therapy Forecasted Market Size by Region (2026-2035)
2.3 Cell and Gene Therapy Market Dynamics
2.3.1 Cell and Gene Therapy Industry Trends
2.3.2 Cell and Gene Therapy Market Drivers
2.3.3 Cell and Gene Therapy Market Challenges
2.3.4 Cell and Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Players by Revenue (2021-2026)
3.1.2 Global Cell and Gene Therapy Revenue Market Share by Players (2021-2026)
3.2 Global Cell and Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Revenue
3.4 Global Cell and Gene Therapy Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Revenue in 2026
3.5 Cell and Gene Therapy Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Breakdown Data by Type
4.1 Global Cell and Gene Therapy Historic Market Size by Type (2021-2026)
4.2 Global Cell and Gene Therapy Forecasted Market Size by Type (2026-2035)
5 Cell and Gene Therapy Breakdown Data by Application
5.1 Global Cell and Gene Therapy Historic Market Size by Application (2021-2026)
5.2 Global Cell and Gene Therapy Forecasted Market Size by Application (2026-2035)
6 North America
6.1 North America Cell and Gene Therapy Market Size (2021-2035)
6.2 North America Cell and Gene Therapy Market Growth Rate by Country: 2021 VS 2026 VS 2035
6.3 North America Cell and Gene Therapy Market Size by Country (2021-2026)
6.4 North America Cell and Gene Therapy Market Size by Country (2026-2035)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Market Size (2021-2035)
7.2 Europe Cell and Gene Therapy Market Growth Rate by Country: 2021 VS 2026 VS 2035
7.3 Europe Cell and Gene Therapy Market Size by Country (2021-2026)
7.4 Europe Cell and Gene Therapy Market Size by Country (2026-2035)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Market Size (2021-2035)
8.2 Asia-Pacific Cell and Gene Therapy Market Growth Rate by Region: 2021 VS 2026 VS 2035
8.3 Asia-Pacific Cell and Gene Therapy Market Size by Region (2021-2026)
8.4 Asia-Pacific Cell and Gene Therapy Market Size by Region (2026-2035)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Market Size (2021-2035)
9.2 Latin America Cell and Gene Therapy Market Growth Rate by Country: 2021 VS 2026 VS 2035
9.3 Latin America Cell and Gene Therapy Market Size by Country (2021-2026)
9.4 Latin America Cell and Gene Therapy Market Size by Country (2026-2035)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Market Size (2021-2035)
10.2 Middle East & Africa Cell and Gene Therapy Market Growth Rate by Country: 2021 VS 2026 VS 2035
10.3 Middle East & Africa Cell and Gene Therapy Market Size by Country (2021-2026)
10.4 Middle East & Africa Cell and Gene Therapy Market Size by Country (2026-2035)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Detail
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Cell and Gene Therapy Introduction
11.1.4 Amgen Inc. Revenue in Cell and Gene Therapy Business (2021-2026)
11.1.5 Amgen Inc. Recent Development
11.2 bluebird bio, Inc.
11.2.1 bluebird bio, Inc. Company Detail
11.2.2 bluebird bio, Inc. Business Overview
11.2.3 bluebird bio, Inc. Cell and Gene Therapy Introduction
11.2.4 bluebird bio, Inc. Revenue in Cell and Gene Therapy Business (2021-2026)
11.2.5 bluebird bio, Inc. Recent Development
11.3 Dendreon Pharmaceuticals LLC.
11.3.1 Dendreon Pharmaceuticals LLC. Company Detail
11.3.2 Dendreon Pharmaceuticals LLC. Business Overview
11.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Introduction
11.3.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Business (2021-2026)
11.3.5 Dendreon Pharmaceuticals LLC. Recent Development
11.4 Fibrocell Science, Inc.
11.4.1 Fibrocell Science, Inc. Company Detail
11.4.2 Fibrocell Science, Inc. Business Overview
11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Introduction
11.4.4 Fibrocell Science, Inc. Revenue in Cell and Gene Therapy Business (2021-2026)
11.4.5 Fibrocell Science, Inc. Recent Development
11.5 Human Stem Cells Institute
11.5.1 Human Stem Cells Institute Company Detail
11.5.2 Human Stem Cells Institute Business Overview
11.5.3 Human Stem Cells Institute Cell and Gene Therapy Introduction
11.5.4 Human Stem Cells Institute Revenue in Cell and Gene Therapy Business (2021-2026)
11.5.5 Human Stem Cells Institute Recent Development
11.6 Kite Pharma, Inc.
11.6.1 Kite Pharma, Inc. Company Detail
11.6.2 Kite Pharma, Inc. Business Overview
11.6.3 Kite Pharma, Inc. Cell and Gene Therapy Introduction
11.6.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Business (2021-2026)
11.6.5 Kite Pharma, Inc. Recent Development
11.7 Kolon TissueGene, Inc.
11.7.1 Kolon TissueGene, Inc. Company Detail
11.7.2 Kolon TissueGene, Inc. Business Overview
11.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Introduction
11.7.4 Kolon TissueGene, Inc. Revenue in Cell and Gene Therapy Business (2021-2026)
11.7.5 Kolon TissueGene, Inc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Cell and Gene Therapy Introduction
11.8.4 Novartis AG Revenue in Cell and Gene Therapy Business (2021-2026)
11.8.5 Novartis AG Recent Development
11.9 Orchard Therapeutics plc.
11.9.1 Orchard Therapeutics plc. Company Detail
11.9.2 Orchard Therapeutics plc. Business Overview
11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Introduction
11.9.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Business (2021-2026)
11.9.5 Orchard Therapeutics plc. Recent Development
11.10 Organogenesis Holdings Inc.
11.10.1 Organogenesis Holdings Inc. Company Detail
11.10.2 Organogenesis Holdings Inc. Business Overview
11.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Introduction
11.10.4 Organogenesis Holdings Inc. Revenue in Cell and Gene Therapy Business (2021-2026)
11.10.5 Organogenesis Holdings Inc. Recent Development
11.11 Pfizer, Inc.
11.11.1 Pfizer, Inc. Company Detail
11.11.2 Pfizer, Inc. Business Overview
11.11.3 Pfizer, Inc. Cell and Gene Therapy Introduction
11.11.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Business (2021-2026)
11.11.5 Pfizer, Inc. Recent Development
11.12 RENOVA THERAPEUTICS
11.12.1 RENOVA THERAPEUTICS Company Detail
11.12.2 RENOVA THERAPEUTICS Business Overview
11.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Introduction
11.12.4 RENOVA THERAPEUTICS Revenue in Cell and Gene Therapy Business (2021-2026)
11.12.5 RENOVA THERAPEUTICS Recent Development
11.13 Shanghai Sunway Biotech Co., Ltd.,
11.13.1 Shanghai Sunway Biotech Co., Ltd., Company Detail
11.13.2 Shanghai Sunway Biotech Co., Ltd., Business Overview
11.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Introduction
11.13.4 Shanghai Sunway Biotech Co., Ltd., Revenue in Cell and Gene Therapy Business (2021-2026)
11.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Development
11.14 Sibiono GeneTech Co. Ltd.,
11.14.1 Sibiono GeneTech Co. Ltd., Company Detail
11.14.2 Sibiono GeneTech Co. Ltd., Business Overview
11.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Introduction
11.14.4 Sibiono GeneTech Co. Ltd., Revenue in Cell and Gene Therapy Business (2021-2026)
11.14.5 Sibiono GeneTech Co. Ltd., Recent Development
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Detail
11.15.2 Spark Therapeutics, Inc. Business Overview
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Introduction
11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Business (2021-2026)
11.15.5 Spark Therapeutics, Inc. Recent Development
11.16 Vericel Corporation
11.16.1 Vericel Corporation Company Detail
11.16.2 Vericel Corporation Business Overview
11.16.3 Vericel Corporation Cell and Gene Therapy Introduction
11.16.4 Vericel Corporation Revenue in Cell and Gene Therapy Business (2021-2026)
11.16.5 Vericel Corporation Recent Development
11.17 ViroMed Co., Ltd.
11.17.1 ViroMed Co., Ltd. Company Detail
11.17.2 ViroMed Co., Ltd. Business Overview
11.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Introduction
11.17.4 ViroMed Co., Ltd. Revenue in Cell and Gene Therapy Business (2021-2026)
11.17.5 ViroMed Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
